Dayal, S., Aluri, J., Hall, N., Filippov, G., Moline, M., Reyderman, L., & Landry, I. (2021). Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant. Pharmacol Res Perspect.
Chicago-tyylinen lähdeviittausDayal, Satish, Jagadeesh Aluri, Nancy Hall, Gleb Filippov, Margaret Moline, Larisa Reyderman, ja Ishani Landry. "Effect of Hepatic Impairment On Pharmacokinetics, Safety, and Tolerability of Lemborexant." Pharmacol Res Perspect 2021.
MLA-viiteDayal, Satish, et al. "Effect of Hepatic Impairment On Pharmacokinetics, Safety, and Tolerability of Lemborexant." Pharmacol Res Perspect 2021.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.